https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35727 Wed 14 Jun 2023 12:38:16 AEST ]]> Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52763 Tue 14 Nov 2023 15:23:12 AEDT ]]> Business as unusual: medical oncology services adapt and deliver during COVID-19 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46933 Thu 08 Dec 2022 13:52:16 AEDT ]]> Supportive care of women with breast cancer: key concerns and practical solution https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29649 Sat 24 Mar 2018 07:41:51 AEDT ]]>